← Evidence map

ArticleLeukemia2018

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.

M-A Hospital et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28914261